This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (34)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

J. Richard Wittenborn, PhD; Emile S.P. Weber, MD; Mary Brown

Arch Gen Psychiatry. 1973;28(3):308-315.

Abstract
A comprehensive study was done to determine the efficacy of niacin as a supplement in the treatment of schizophrenic patients over a two-year period. Newly admitted schizophrenic men were assigned at random to either high-dosage niacin (3,000 mg/day) or low-dosage niacin (6 mg/day) as a control medication. The only significant untoward result was the occurrence of a pigmented hyperkeratosis in about one third of the patients receiving the high-dosage regimen.

Analyses of rating scale, social adjustment, and self-report data for patients in treatment at least 18 months failed to indicate any advantage for the high dosage of nicotinic acid group. Rate of attrition, duration of hospitalization, and need for tranquilizing medication failed also to reveal an advantage for this group.

Author Affiliations
New Brunswick, NJ

From Rutgers University, New Brunswick, NJ.

Footnotes
Accepted for publication Nov 20, 1972.

Reprint requests to Interdisciplinary Research Center, Rutgers University, New Brunswick, NJ 08903 (Dr. Wittenborn).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Persisting Symptoms in Schizophrenia Predicted by Background Factors
Wittenborn et al.
Arch Gen Psychiatry 1977;34:1057-1061.
ABSTRACT  

Stability of Symptom Ratings for Schizophrenic Men
Wittenborn
Arch Gen Psychiatry 1977;34:437-440.
ABSTRACT  

A Search for Responders to Niacin Supplementation
Wittenborn
Arch Gen Psychiatry 1974;31:547-552.
ABSTRACT